Characteristics | Total | CTC pos | In % | P-value |
---|---|---|---|---|
Total | 502 | 97 | 19 | - |
Tumor Size | Â | Â | Â | Â |
   pT1 | 322 | 58 | 18 | 0.32 |
   pT2-4 | 180 | 39 | 22 |  |
Nodal Status | Â | Â | Â | Â |
   Negative | 340 | 65 | 19 | 0.79 |
   Positive | 159 | 32 | 20 |  |
Histology | Â | Â | Â | Â |
   Ductal | 392 | 78 | 20 | 0.83 |
   Lobular | 77 | 13 | 17 |  |
   Others | 30 | 6 | 20 |  |
Grading | Â | Â | Â | Â |
G I | 95 | 18 | 19 | 0.68 |
G II | 290 | 53 | 18 | Â |
G III | 113 | 25 | 22 | Â |
ER status | Â | Â | Â | Â |
Positive | 415 | 77 | 19 | 0.34 |
Negative | 87 | 20 | 23 | Â |
PR status | Â | Â | Â | Â |
Positive | 382 | 72 | 19 | 0.63 |
Negative | 120 | 25 | 21 | Â |
HER2 status | Â | Â | Â | Â |
Negative | 437 | 83 | 19 | 0.50 |
Positive | 62 | 14 | 23 | Â |
DTC | Â | Â | Â | Â |
Negative | 367 | 69 | 19 | 0.41 |
Positive | 107 | 24 | 21 | Â |
Subtype by IHC | Â | Â | Â | Â |
(ER-, PR-, HER2-) | 58 | 14 | 24 | 0.62 |
(ER-, PR-, HER2+) | 17 | 3 | 18 | Â |
(ER+ and/or PR+) | 424 | 80 | 19 | Â |